Jazz Pharmaceuticals (JAZZ)
NASDAQ: JAZZ
· Real-Time Price · USD
119.22
1.55 (1.32%)
At close: Aug 19, 2025, 3:59 PM
119.75
0.44%
After-hours: Aug 19, 2025, 07:42 PM EDT
Jazz Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 1.05B | 897.84M | 1.09B | 1.05B | 1.02B | 901.98M | 1.01B | 972.14M | 957.32M | 892.81M | 972.12M | 940.65M | 932.88M | 813.72M | 896.73M | 838.12M | 751.81M | 607.58M |
Cost of Revenue | 278.37M | 104.62M | 128.71M | 111.61M | 109.9M | 95.49M | 107.24M | 102.15M | 97.54M | 128.64M | -106.03M | 133.66M | 124.21M | 115.28M | 136.15M | 145.22M | 119.19M | 40.19M |
Gross Profit | 767.34M | 793.22M | 959.46M | 943.36M | 913.92M | 806.5M | 904.69M | 869.99M | 859.78M | 764.17M | 1.08B | 806.99M | 808.67M | 698.44M | 760.58M | 692.89M | 632.62M | 567.39M |
Operating Income | 218.97M | -55.89M | 190.77M | 260.21M | 199.44M | 66.21M | 122.5M | 172.39M | 157.64M | 126.06M | -263.39M | 24.76M | 85.55M | 87.55M | 49.38M | 28.37M | -69.59M | 162.12M |
Interest Income | 19.1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -735.64M | -109.81M | 133.22M | 200.81M | 137.93M | -2.95M | 61.53M | 99.52M | 81.78M | 54.1M | -339.99M | -63.45M | 18.55M | 2.18M | -44.83M | -67.63M | -136.06M | 139.85M |
Net Income | -718.47M | -92.54M | 191.12M | 215.06M | 168.57M | -14.62M | 94.15M | 146.82M | 104.44M | 69.42M | -239.95M | -19.65M | 34.66M | 1.65M | -35.35M | -52.83M | -363.32M | 121.83M |
Selling & General & Admin | 358.4M | 514.01M | 369.29M | 325.77M | 338.52M | 351.71M | 334.31M | 308.31M | 340.84M | 297.92M | 383.2M | 358.48M | 366.47M | 308.81M | 398.46M | 363.68M | 429.03M | 260.51M |
Research & Development | 189.97M | 180.65M | 240.5M | 199.92M | 220.73M | 222.85M | 216.61M | 234.4M | 209.24M | 189.41M | 172.56M | 148.87M | 139.05M | 129.98M | 155.44M | 141.04M | 132.7M | 76.57M |
Other Expenses | n/a | 154.45M | 158.9M | 157.46M | 155.22M | 165.73M | 231.28M | 154.88M | 152.06M | 149.79M | 785.78M | 274.88M | 217.6M | 172.09M | 157.29M | 159.8M | 140.48M | 68.19M |
Operating Expenses | 548.37M | 849.11M | 768.69M | 683.15M | 714.48M | 740.29M | 782.2M | 697.6M | 702.14M | 637.11M | 1.34B | 782.23M | 723.12M | 610.89M | 711.2M | 664.52M | 702.21M | 405.27M |
Interest Expense | 66.06M | 53.71M | 51.26M | 58.7M | 62.02M | 66.12M | 70.32M | 71.5M | 73.47M | 74.15M | 74.13M | 80.24M | 63.19M | 70.68M | 88.6M | 93.37M | 69.42M | 27.38M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 826.74M | 953.73M | 897.4M | 794.76M | 824.38M | 835.78M | 889.44M | 799.75M | 799.68M | 765.76M | 1.24B | 915.89M | 847.33M | 726.17M | 847.35M | 809.75M | 821.4M | 445.46M |
Income Tax Expense | -17.17M | -17.81M | -57.91M | -14.53M | -30.65M | 11.67M | -33.09M | -47.18M | -24.32M | -15.32M | -100.04M | -43.03M | -16.11M | 536K | -12.47M | -18.06M | 228.62M | 18.02M |
Shares Outstanding (Basic) | 61.19M | 60.98M | 60.54M | 61.41M | 62.88M | 62.54M | 62.58M | 63.11M | 63.99M | 63.49M | 63.05M | 62.78M | 62.44M | 61.87M | 61.5M | 61.28M | 59.45M | 56.47M |
Shares Outstanding (Diluted) | 61.19M | 60.98M | 61.5M | 63.17M | 69.63M | 62.54M | 69.67M | 71.29M | 73.54M | 73.77M | 63.05M | 62.78M | 63.43M | 62.91M | 61.5M | 61.28M | 59.45M | 58.39M |
EPS (Basic) | -11.74 | -1.52 | 3.16 | 3.50 | 2.68 | -0.23 | 1.50 | 2.33 | 1.63 | 1.09 | -3.81 | -0.31 | 0.56 | 0.03 | -0.57 | -0.86 | -6.11 | 2.16 |
EPS (Diluted) | -11.74 | -1.52 | 3.11 | 3.42 | 2.49 | -0.23 | 1.42 | 2.14 | 1.52 | 1.04 | -3.81 | -0.31 | 0.55 | 0.03 | -0.57 | -0.86 | -6.11 | 2.09 |
EBITDA | -495.49M | 108.77M | 383.84M | 424.74M | 362.48M | 251.65M | 310.39M | 334.95M | 328.76M | 297.21M | -114.04M | 172.44M | 240.41M | 254.27M | 208.39M | 193.31M | 79.91M | 235.09M |
EBIT | -669.5M | -56.1M | 160.72M | 259.51M | 199.95M | 88.27M | 234.55M | 171.01M | 169.18M | 139.85M | -258.77M | 23.61M | 84.2M | 74.56M | 43.77M | 25.74M | -67.41M | 163.06M |
Depreciation & Amortization | 174.01M | 164.87M | 168.42M | 164.53M | 163.03M | 163.38M | 159.2M | 162.56M | 159.58M | 157.36M | 144.73M | 148.83M | 156.2M | 179.71M | 164.62M | 167.58M | 147.31M | 72.97M |